Publicacións en colaboración con investigadores/as de Hospital General de Castellón (19)

2024

  1. Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement — A Multicenter Cross-Sectional CLINI-AEDV Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 1, pp. 36-47

2023

  1. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  2. Experience with the ENDMAP project, a training activity for Family Doctors in Endocrinology and Nutrition

    Atencion Primaria Practica, Vol. 5, Núm. 4

2022

  1. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  2. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  2. Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry

    PLoS ONE, Vol. 16, Núm. 2 February

  3. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2019

  1. A multifaceted individualized pneumoperitoneum strategy for laparoscopic colorectal surgery: a multicenter observational feasibility study

    Surgical Endoscopy, Vol. 33, Núm. 1, pp. 252-260

2016

  1. An assessment of the management of spasticity in Spain: The 5E study

    Revista de Neurologia, Vol. 63, Núm. 7, pp. 289-296

  2. Potential risk for inappropriate dyslipidemia screening in Primary Care in Spain

    Revista del Laboratorio Clinico, Vol. 9, Núm. 2, pp. 48-53

  3. Request of thyroid function tests from Primary Care in Spain

    Endocrinologia y Nutricion, Vol. 63, Núm. 1, pp. 19-26

  4. Sarcoidosis: an update on current pharmacotherapy options and future directions

    Expert Opinion on Pharmacotherapy, Vol. 17, Núm. 18, pp. 2431-2448

2015

  1. The concordance between patients' renal replacement therapy choice and definitive modality: Is it a utopia?

    PLoS ONE, Vol. 10, Núm. 10

2014

  1. A study of the differences in the request of glycated hemoglobin in primary care in Spain: A global, significant, and potentially dangerous under-request

    Clinical Biochemistry, Vol. 47, Núm. 12, pp. 1104-1107

  2. Variation in laboratory tests ordered for patients treated in hospital emergency departments

    Emergencias, Vol. 26, Núm. 6, pp. 450-458

2010

  1. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain

    Journal of Clinical Microbiology, Vol. 48, Núm. 11, pp. 4200-4206

2008

  1. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229